FIELD: medicine. SUBSTANCE: method involves monitoring arterial blood pressure and patients possessing daybreak hypertension syndrome receive ZINT at night, patients possessing daytime hypertension syndrome take ZINT in the morning. The initial dose of the preparation is equal to 0.1 mg and then 0.1-0.6 mg. EFFECT: improved hemodynamic and metabolism changed due to given pathological process.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING ARTERIAL HYPERTENSION IN CLIMACTERIC PERIOD | 1997 |
|
RU2133608C1 |
| METHOD OF DIFFERENTIATED ADMINISTRATION OF MOXONIDINE IN PATIENTS WITH ARTERIAL HYPERTENSION AT BACKGROUND OF METABOLIC SYNDROME | 2010 |
|
RU2426543C1 |
| METHOD OF TREATING BENIGN HYPERPLASTIC ENDOMETRIAL PROCESSES IN PATIENTS WITH METABOLIC SYNDROME | 2010 |
|
RU2438662C1 |
| METHOD OF TREATING METABOLIC SYNDROME | 2011 |
|
RU2457834C1 |
| METHOD OF TREATING METABOLIC SYNDROME | 2009 |
|
RU2398562C1 |
| METHOD OF TREATING PATIENTS WITH CARDIOVASCULAR DISEASES | 2013 |
|
RU2543468C2 |
| METHOD FOR DIET AND PREVENTIVE NUTRITION IN AGE-RELATED CARDIOVASCULAR CHANGES IN INDIVIDUAL | 2012 |
|
RU2483745C1 |
| METHOD OF TREATING ARTERIAL HYPERTENSION WITH METABOLIC SYNDROME | 2011 |
|
RU2504390C2 |
| METHOD FOR PREDICTING ISCHEMIC CARDIAC DISEASE IN PATIENTS WITH ARTERIAL HYPERTENSION | 2006 |
|
RU2316995C1 |
| METHOD OF ASSESSMENT OF EFFICIENCY AND SAFETY OF ANTIHYPERTENSIVE PREPARATIONS | 1997 |
|
RU2146876C1 |
